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ABSTRACT: Cocaine dependence displays a broad impairment
in cognitive performance including attention, learning, and
memory. To obtain a better understanding of the action of
cocaine in the nervous system, and the relation between
phospholipids and memory, we have investigated whether
phospholipids recover in the brain following cocaine removal
using the fly model, Drosophila melanogaster. In addition, the effects
of methylphenidate, a substitute medication for cocaine depend-
ence, on fly brain lipids after cocaine abuse are also determined to
see if it can rescue the lipid changes caused by cocaine. Time of
flight secondary ion mass spectrometry with a (CO2)6000
+ gas
cluster ion beam was used to detect intact phospholipids. We show
that cocaine has persistent effects, both increasing and decreasing
the levels of specific phosphatidylethanolamines and phosphatidylinositols. These changes remain after cocaine withdrawal and are
not rescued by methylphenidate. Cocaine is again shown to generally increase the levels of phosphatidylcholines in the fly brain;
however, after drug withdrawal, the abundance of these lipids returns to the original level and methylphenidate treatment of the flies
following cocaine exposure enhances the reversal of the lipid level reducing them below the original control. The study provides
insight into the molecular effects of cocaine and methylphenidate on brain lipids. We suggest that phosphatidylcholines could be a
potential target for the treatment of cocaine abuse as well as be a significant hallmark of cognition and memory loss with cocaine.
KEYWORDS: Mass spectrometry imaging, lipids, cocaine removal, methylphenidate, Drosophila
■ INTRODUCTION
Cocaine addiction is a worldwide serious health problem. One
of the primary mechanisms of cocaine action is its ability to
block presynaptic dopamine transporters which results in an
increase in dopamine levels in the synaptic cleft resulting in
euphoria and reinforcement of the administration of cocaine.
Once the dopamine transporters are blocked by cocaine, most
of the dopamine in the synaptic cleft cannot be recycled via
reuptake.1 Consequently, long-term repeated cocaine exposure
inhibits dopamine transporters and consequently causes
depletion of dopamine concentration and dysregulation of
dopamine signaling in the brain.2 Neurochemical actions of
cocaine also lead to an increase or a decrease in intracellular
activities, especially the synthesis and degradation of
phospholipids, in the reward-related brain regions which are
associated with learning and memory.3 These changes in the
brain might contribute to the deficit of brain functions
observed including memory and cognition loss. Intriguingly,
there is increasing literature showing that the symptoms of
cognitive impairment are persistent long after cocaine
withdrawal.4 However, there is still no effective medication
available for cocaine abuse to date. One of the pharmacother-
apeutic approaches for cocaine treatment is agonist replace-
ment therapy in which methylphenidate (MPH), for instance,
can be used as a potential substitution for cocaine to reduce
the cycle of compulsive use of cocaine. MPH also inhibits
dopamine reuptake which induces drug addiction; however, its
clearance in the brain is slower and therefore the abuse
potential is lower compared to cocaine. MPH has been shown
to exert opposite effects to cocaine on cognitive function;
noticeably, it helps improve focus and memory for attention
deficit hyperactivity disorder (ADHD) patients. Therefore,
MPH might be a good candidate for treatment of cognition
deficit caused by cocaine abuse.
Phospholipids are highly abundant in the brain and play
important roles in brain function. Specifically, phospholipids
regulate membrane trafficking, membrane fusion during
exocytosis and endocytosis, regulate neurotransmitter recep-
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tors for neuronal signaling and transmission, and supply energy
for brain activity.5 Phospholipids are composed of different
groups with specific types of headgroups and tails, which
determines their physical and chemical properties as well as
their shapes and morphologies. These properties in turn result
in different effects of the lipids on the activities of other
neuronal molecules, for example, alteration of presynaptic
protein interactions, activity of ion channels, and membrane
curvature and fluidity.6 Phosphatidylcholines (PCs) and
cholesterol have been shown to diminish in the cellular
membrane of PC12 cells following exposure to cisplatin, and
this is suggested as a molecular mechanism underlying the
change of neurotransmitter release by this drug.7 In addition,
various neurological disorders and brain diseases such as
Alzheimer’s, ischemic stroke, ADHD, and schizophrenia have
been shown to result in alteration of brain lipids regarding their
localization, abundance, and metabolism.8−12 MPH, as a
common drug for ADHD patients, has been shown to change
the lipid structure of the Drosophila melanogaster brain,
especially by decreasing the abundance of cylindrical shaped
PCs, and increasing the amount of conical shaped
phosphatidylethanolamine (PEs) and phosphatidylinositols
(PIs).13 Furthermore, from our previous study comparing
the effects of cocaine and MPH on the lipid structure of the fly
brain,14 it is apparent that these two drugs lead to opposite
changes in differing phospholipid levels. In that work, we
hypothesized this as a possible mechanism for the opposite
effects of cocaine and MPH on learning and memory.
Mass spectrometry imaging (MSI) is a powerful tool for
spatial interrogation of altered lipid biochemistry as a result of
disease or exposure to exogenous compounds such as
cocaine.15,16 One of the MSI techniques, time-of-flight
secondary ion mass spectrometry (ToF-SIMS), has been
increasingly used in bioimaging to explore the lipid molecular
architecture of cells and tissues.17 Given the high complexity
and heterogeneity of the brain, it is essential to obtain detailed
spatial organization in order to gain the insight of the relations
between the molecular structure and function of the brain.
ToF-SIMS offers the advantage that various molecules can be
analyzed in parallel to obtain rich spatial molecular information
inside the brain. The use of a high energy gas cluster ion beam
(GCIB) with ToF-SIMS makes it particularly well suited for
imaging intact phospholipids owing to the reduced fragmenta-
tion that occurs during sputtering by large primary ion clusters
which therefore preserves the molecular ions.18,19
In this paper, we use ToF-SIMS imaging to test the
hypothesis that the withdrawal of cocaine or addition of MPH
after drug in Drosophila brain reverses the dramatic changes in
the brain lipid composition caused by exposure to cocaine. We
have investigated if this strategy can be used to rescue the
adverse effects of cocaine on lipid composition and brain
functions. Interestingly, we find that cocaine removal as well as
MPH treatment after cocaine only partially reverse the
phospholipid changes in the brain caused by cocaine. This
treatment seems to amplify the effects of cocaine removal on
PCs and partially on triacylglycerols (TAGs), but neither
cocaine removal nor MPH alters the levels of PE and PI
species determined to change after cocaine. These seem to be
more permanent changes that cannot be easily rescued.
■ RESULTS AND DISCUSSION
ToF-SIMS is a powerful approach for studying lipidomic
profiles and distributions in biological tissues. Due to the use of
the relatively new GCIB technology, ion sources such as
Ar4000
+ and (CO2)6000
+ provide greatly enhanced sputter yields
of high mass molecular ions. Thus, a variety of intact
phospholipids can be detected in fly brain sections. In order
to evaluate the long-term effect of cocaine withdrawal or follow
up MPH treatment on the phospholipid structure of the brain,
we used ToF-SIMS with a (CO2)6000
+ GCIB to image
phospholipid localization in fly brain sections after the different
drug treatments. One group of flies was treated with cocaine
for 3 days and then fed with normal yeast-based food for 3
more days. Another set of cocaine-treated flies was
subsequently treated by oral administration of MPH for 3
days. Comparison of the ion images of individual phospholipid
species indicates a clear change in their distribution after
cocaine removal or MPH treatment. In the positive ion mode,
in the control flies, PCs, for instance PC (36:1), are mostly
located in the central brain and some parts of optical lobe,
especially the lobula complex (Figure 1A). Interestingly, the
PC species spread out to the medulla region of the optical lobe
in the cocaine-treated brain, whereas after cocaine removal
their distributions return to those observed in the control
group. In addition, the regional intensity of PC species
increases in abundance mostly in the central brain after cocaine
and then decreases to control levels after cocaine removal, but
it shows even lower abundance and is more focused in the
Figure 1. ToF-SIMS ion images show accumulation of phospholipids
in fly head analyzed by ToF-SIMS with a 40 keV (CO2)6000
+ GCIB.
(A) PC (36:1), [M + H]+, in positive ion mode, (B, C) PE (34:1) and
PE (36:3), [M − H]−, in negative ion mode, (D) PI (36:3), [M −
H]−, in negative ion mode. Primary ion dose density 1.7 × 1013 ions/
cm2. Image area is 1000 × 1000 μm2 and 256 × 256 pixels. Scale bar
is 200 μm. Signal intensity is displayed on a color thermal scale on the
right panel. Symbolic figure on the top left shows the orientation of
the fly head section: two red parts are medullas of optical lobes, two
green parts are optical lobula, central brain is the yellow part in the
middle, and gray part is proboscis.
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central brain region of cocaine-fed flies when followed by
MPH administration during cocaine removal.
In the negative ion mode, the data show that PE and PI
species are distributed more evenly across the whole control
brain, while showing slightly higher intensity in the central
brain and optical lobe regions. After cocaine administration,
there are different trends in the distributions. For example, an
enhancement of PE (34:1) intensity is observed in the cocaine-
treated flies compared to the control flies. This is more or less
uniform across the brain, but it appears a little stronger in the
optical lobes. This increase remains at the same level after the
flies are removed from cocaine exposure for 3 days, and the
abundance is even more pronounced after being treated by
MPH following the cocaine (Figure 1B). In contrast to PE
(34:1), unsaturated PEs and PIs with 36 carbons in the fatty
acid chains are decreased in the central brain and the optical
lobe in the cocaine-fed fly brains compared to control flies.
These also remain unchanged after cocaine removal, or after
MPH treatment (Figure 1C, D), although PI, such as PI
(36:3), appears to recover slightly in the brains treated with
MPH during cocaine recovery (semiquantitative data are given
below). Overall, the data show that cocaine removal and MPH
treatment after cocaine exposure reverse the effects of cocaine
on the PC distributions in the fly brain, whereas there is no
significant reversal in the changes in the perturbed PE and PI
lipids caused by cocaine when it is removed or the flies are
exposed to MPH during the recovery time.
Previous work showed that the effects of cocaine on the fly
brain were most prevalent in the alteration of phospholipid
compositions mainly in the central brain area, but no
significant changes were observed in the optical regions and
proboscis.14 In the current study, all the peaks in the spectra
have been collected from the central regions of the fly brain,
and to elucidate the chemical changes principal components
analysis (PCA) was performed on ToF-SIMS spectra. These
were normalized to the number of selected pixels and total ion
counts. The score plot of PCA from the extracted data clearly
distinguishes three different groups along the second and third
principal components.
Figure 2A shows a clear separation in principal component 3
for the control and cocaine removal groups from the drug-
treated groups. In Figure 2B, the loadings plot of principal
component 3 is included showing which peaks contribute most
to the separation observed in the score plot of principal
component 3. The separation is mainly caused by peaks in the
intact lipid region (e.g., TAG and PC species). The assignment
of peaks, which show significant alterations in principal
component 3, can be found in Table S1. From Figure 2B,
PC species, for example PC (36:1) at m/z 788.6, PC (34:1) +
K at m/z 798.5, and PC (36:3) + K at m/z 822.5, are more
abundant in the purely cocaine-fed group and the group fed
cocaine followed by MPH treatment. Likewise, other frag-
ments of PC salt adducts such as PC (34:2) + Na-TMA at m/z
721.5 and PC (36:2) + Na-TMA at m/z 749.5, where TMA
(59 Da) is the trimethylamine group at the end of the PC
headgroup, display more intense intensity in cocaine-fed flies
and cocaine-fed flies followed by MPH treatment. In contrast,
elevations of the levels of TAG salt adducts, such as TAG
(48:1) + Na at m/z 827.7, TAG (48:1) + K at m/z 843.7, and
TAG (50:1) + K at m/z 871.7, are observed in control brains
and those after cocaine removal. The diacylglycerol (DAG)
peaks in the mass range m/z 400−650 are probably the
fragments from TAGs and other lipids; hence, we did not
attempt to identify these species. In addition, use of principal
component 2 separates the cocaine-fed group from the
cocaine-fed followed by MPH group (Figure S1). Specifically
the PCA results suggest that the control, cocaine-fed, and
cocaine removal groups have higher abundances of PCs and
their salt adducts, such as PC (34:1) at m/z 760.6, PC (36:2)
+ K at m/z 824.6, and PC (36:2) + K-TMA at m/z 765.5,
compared to the cocaine-fed group followed by MPH
treatment. The signal level for the PC headgroup at m/z
184.1, which is correlated with PC species, is also decreased in
cocaine-treated flies followed by MPH during the cocaine
removal time. In contrast, the flies fed cocaine followed by
MPH treatment during the cocaine removal time have spectra
that are more dominant in the content of TAGs, for example,
TAG (48:1) + K at m/z 843.7, TAG (50:2) + Na at m/z
853.7, and TAG (52:2) + Na at m/z 881.8.
While the PCA analysis can indicate which species may be
related to the separation of the peaks the nature of the scores
and loadings output can make precise interpretation difficult.
Hence it is critical that one returns to the raw data for further
validation. Therefore, to obtain detailed information about the
alterations in phospholipid compositions in fly brains after
drug treatments and removal, the lipid species identified by
PCA were selected and their relative concentrations were
compared among different groups. Figure 3 shows that there
are significant changes in PC levels after drug treatment
compared to control. PCs detected as [M + H]+ and their salt
adducts are increased in the fly brains after cocaine
administration. The elevation of PC abundance is mainly
observed in PC species with 32, 34, and 36 carbon fatty acid
chains and different saturation levels, such as PC (32:1) at m/z
732.6, PC (32:0) at m/z 734.6, PC (34:2) at m/z 758.6, PC
Figure 2. PCA for ToF-SIMS data in positive mode. (A) Score plot of
the second principal component versus the third principal
component; (B) corresponding loadings for the third principal
component. The ellipse on the score plot calculated from Hotelling’s
T-square statistic is related to the 95% confidence interval.
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(34:1) at m/z 760.6, PC (36:2) at m/z 786.6, and PC (36:1)
at m/z 788.6. After cocaine removal, the levels of these PC
species in the central brain return to the same level as in the
control brains. MPH treatment during the removal time after
cocaine exposure, however, induces further depletion in the PC
levels compared to the control brains, which is consistent with
observations in our previous reports13,14 and the images in
Figure 1.
The relative amounts of TAGs in different fly brain groups
are shown in Figure S2. Cocaine induces a dramatic decrease
in TAG levels, and these recover partially after cocaine
removal. MPH treatment after cocaine exposure and removal
leads to recovery of the TAG levels to an even greater extent,
but still lower than those in the control. Based on these data,
we conclude that cocaine removal leads to recovery of the
effects of cocaine on the abundance of PCs, and MPH further
reverses the effects of cocaine on these phospholipids to an
extent past control values. In addition, both treatment
strategies can also partially rescue the change in TAG
concentrations in fly brains following cocaine exposure.
We observe that PC levels are increased in the central fly
brain following cocaine exposure. An elevation of PC
abundance was also observed in rat brains treated with other
stimulants which also induces the impairment of cognitive
performance.20 There are now several pieces of evidence
suggesting that brain phospholipids, especially PCs, are
involved in brain function and mental performance.21,22 PCs
are closely related to the production of choline which is a
precursor for acetylcholine, a neurotransmitter that plays many
biological roles in developmental and cognitive function.23 PC
levels decrease again to normal levels in fly brains after cocaine
removal or after MPH treatment. In addition to ADHD
patients, cognitive enhancement following MPH has also been
reported for patients with traumatic brain injury as well as
depression after stroke.24−26 Moreover, Goldstein’s group
showed that the use of a low dose of MPH improved cognitive
tasks in cocaine abusers.27 It is enticing to speculate that the
changes we observe in lipids following cocaine and those
rescued by MPH are in some way involved in these cognitive
changes. It should be noted that incubation of cells with lipids
changes the rate of exocytosis.28,29
PCA was carried out on ToF-SIMS spectra in the negative
ion mode to elucidate the difference for the recovery of PEs
and PIs between the control and drug-treated groups. The
PCA score plot of principal component 1 versus principal
component 2, which together capture 58% of the total variance
in the data set, is shown in Figure 4. The control group is
clearly separated from the others across principal component 2,
whereas all the drug treated groups, including the cocaine
exposure, cocaine removal, and cocaine exposure followed by
MPH groups, overlap in the scores plot (Figure 4A).
The peaks contributing to the difference between the control
and the other groups in the PCA can be identified by the
loading plot of principal component 2 (Figure 4B). The
significant lipids that are decreased in the drug-treated brains
versus control are PE/PI species such as PE (36:2) at m/z
742.5, PI (36:4) at m/z 857.5, and PI (36:3) at m/z 859.5,
lysolipids such as lysophosphatidic acid LPA (18:1) at m/z
435.3, lysophosphatidylethanolamine LPE (18:1) at m/z
478.3, and lysophosphatidylinositol LPI (18:1) at m/z 597.3,
and fatty acids, for example, FA (18:1) at m/z 281.2 and FA
(16:0) at m/z 255.2. In contrast, several PEs and PIs with 34
carbon fatty acid chains, such as PE (34:1) at m/z 716.5, PI
(34:2) at m/z 833.5, and PI (34:1) at m/z 835.5, as well as
fatty acids FA (22:0) at m/z 339.3 and FA (24:0) at m/z 367.4
are increased in the drug-treated groups.
Figure 3. Changes in phosphatidylcholine levels in the central fly
brain after cocaine and cocaine removal, and in flies with cocaine
treatment followed by MPH oral administration in positive ion mode
analyzed using a 40 keV (CO2)6000
+ GCIB. Peak intensity is
normalized to the number of pixels selected and total signal intensity.
Error bars are standard error of the mean of 33 controls (blue bars),
28 cocaine-treated flies (green bars), 27 flies with cocaine withdrawal
(yellow bars), and 27 flies with MPH feeding after cocaine treatment
(red bars). A t test was used to compare the statistical difference
between the cocaine group with the other groups (*p < 0.5, **p <
0.01, ***p < 0.001). No statistical differences were found between
control and cocaine-removed groups (p > 0.05). Ions were detected as
[M + H]+ unless specified as Na/K adduct species.
Figure 4. PCA for ToF-SIMS data in negative mode. (A) Score plot
of the first principal component versus the second principal
component; (B) corresponding loading plot for the second principal
component. The ellipse on the score plot calculated from Hotelling’s
T-square statistic is related to the 95% confidence interval.
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After cocaine administration, there is an accumulation of
PEs and PIs with 34 carbons in the fatty acid chain and a
reduction of PEs and PIs with 36 carbons as well as several
LPA, LPE, and LPI species (Figure S3). PCA, however, shows
no separation between the cocaine administration, cocaine
removal groups, and cocaine-fed flies followed by MPH
treatment. The effect of cocaine on PE and PI phospholipids,
and several lipid precursors in the fly brain is still persistent
even after the flies are removed from the drug as well as treated
with MPH. This is also supported by the comparison of the
relative abundances of various significant lipid species in the fly
brains undergoing different drug treatments (Figure 5). There
is a significant increase in PEs and PIs with 34 carbon fatty acid
chains, including PE (34:2), PE (34:1), PI (34:2), PI (34:1),
and PI (34:0), after cocaine administration and persisting after
cocaine removal and MPH treatment. In contrast, cocaine
exposure decreases the amount of several other lipids, for
instance, PE (30:1) at m/z 660.5, PE (32:1) at m/z 688.5, PE
(36:3) at m/z 740.5, PE (36:2) at m/z 742.5, PI (36:5) at m/z
855.5, PI (36:4) at m/z 857.5, and PI (36:3) at m/z 859.5,
and, again, the withdrawal of cocaine does not recover the
effect of cocaine on these lipids. Similarly, these PE and PI
levels stay the same when flies are subsequently treated with
MPH for 3 days. Overall, cocaine significantly alters the levels
of PEs and PIs and these changes are not reversible by cocaine
removal and subsequent treatment with MPH, at least for 3
days.
Oral administration cocaine results in significant changes in
the phospholipid composition of the fly brain, consistent with
previous results.14 PCs and the 34-carbon chain PEs and PIs
are increased, and total PEs and PIs are decreased after cocaine
exposure. Cocaine administration has been shown to decrease
the activity of phospholipase A2 (PLA2) in the rat brain
striatum due to the increase in dopamine levels.30 A schematic
of the metabolic pathways of phospholipids is provided in
Figure S4. PLA2 is the enzyme responsible for the degradation
of phospholipids at the sn-2 position to release 1-acyl
lysophospholipids and free fatty acids.31 Reduced PLA2 activity
caused by cocaine might be associated with the elevation of
phospholipids, mainly PCs and some PEs and PIs, observed. In
addition, the inhibition of PLA2 induced by psychostimulants
such as cocaine might result in the depletion of lysophospho-
lipids in the fly brain as it is observed in the reduction of LPA
(18:1), LPE (18:1), and LPI (18:1) in the cocaine-treated flies
(Figure 4B). However, the concentrations of PCs in the fly
brain return to normal values after the flies were removed from
cocaine. Thus, if the PLA2 enzyme is responsible for these
increased lipid levels, then it is reversible and its activity is
recovered after cocaine removal.30
Phospholipase C (PLC) is a membrane-associated enzyme
that promotes the conversion of PIs to DAGs. Cocaine has
been found to stimulate PLC activity via the activation of
Gq/11-coupled receptors.
32 PLC activity has also been found to
be increased in the frontal cortex of rats after withdrawal from
repeated administration of cocaine.33,34 As the activity of PLC
increases, PIs are degraded into diacylglycerol and secondary
messenger molecules such as inositol 1,4,5-trisphosphate.
Hence, we propose that the cocaine has long-term effects on
the activity of PLC, which in turn affects the phospholipids in
the long term even after withdrawal. Importantly, these
persistent alterations on PEs and PIs could be associated
with the cognitive deficits observed long after cocaine
withdrawal. Several reports have shown that dysregulation in
cognition and emotion is persistent in subjects even after
cocaine withdrawal, and also after other stimulants.4,35,36 Since
our data show that the depletion of PEs and PIs remain after
cocaine removal, these changes might be associated with the
cognitive impairment caused by cocaine.
An important goal for pharmacotherapeutic medicine of
drug abuse is a therapeutic treatment for cocaine addiction.
Several studies have suggested that MPH can be used as an
agonistic substitute for treatment of cocaine dependence owing
to their similarity in structure and basic mechanism in blocking
dopamine uptake. However, although cocaine and methyl-
phenidate have similar effects in blocking dopamine reuptake,
they have opposite effects on their changing the phospholipid
composition in fly brain.14 Moreover, it has been reported by
Calipari et al. that cocaine and methylphenidate have opposite
effects on the dopaminergic system.37 Cocaine decreased
dopamine transport and dopamine uptake rate and increased
the dopamine release, whereas MPH administration increased
dopamine transporter density, dopamine uptake rate, and
dopamine release. Our data (Figure 3) reveal that PC
abundance in the fly brain has a tendency to increase after
cocaine administration; however, there is a downward trend or
reversal when cocaine is removed, and this downward trend is
exaggerated when the cocaine-fed flies are subsequently treated
with MPH. In contrast, the changes in PEs and PIs in the fly
brain after cocaine exposure are not reversed with cocaine
removal or MPH treatment. Zhu et al. found that cocaine and
MPH cause opposite effects on the release fraction during
exocytosis from PC12 cells.38 They suggested that cocaine
stimulated protein kinase C, which then synthesized
filamentous actin and consequently increased the rate of the
closing of the fusion pore during open and closed exocytosis.
Unlike cocaine, MPH, which shows no effects on actin
immunoactivity,39 shows normal exocytosis similar to control
cells. Thus, a possible mechanistic aspect to the effects of
cocaine and MPH might be that they induce various effects on
Figure 5. Relative amounts of phospholipids in the central fly brain
after cocaine, cocaine removal, and flies with cocaine treatment
followed MPH oral administration in negative ion mode analyzed
using a 40 keV (CO2)6000
+ GCIB. (A) PE levels; (B) PI levels. Peak
intensity is normalized to number of pixels selected and total signal
intensity. Error bars are standard error of the mean 32 controls (blue
bars), 24 cocaine-treated flies (green bars), 26 flies with cocaine
withdrawal (yellow bars), and 24 flies fed with cocaine followed by
MPH (red bars). A t test was used to compare the difference between
the cocaine group and the other groups (*p < 0.5, **p < 0.01, ***p <
0.001). There are no statistical differences between cocaine groups
and the cocaine-removed groups and cocaine-treated followed by
MPH group (p > 0.05). All ions were detected as [M − H]−.
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membrane phospholipids, which then link to the stability of
the fusion pores for exocytosis.
In summary, PCs, PEs, and PIs might be considered to be
therapeutic targets for treatment of cognitive deficit caused by
cocaine. Although cocaine removal and MPH treatment after
cocaine removal do not completely reverse the dramatic
alterations of all phospholipids in the brain caused by cocaine,
they impose a significantly positive effect on the adverse action
of cocaine on PCs and partially on TAGs. The approaches
presented here might be further examined to develop rescue
strategies for cognitive impairment by cocaine addiction.
■ METHODS
Chemicals. All chemicals were purchased from Sigma-Aldrich,
Sweden.
Drosophila Preparation. Wide type Drosophila strain, Canton-S,
was maintained in standard cornmeal food at room temperature (23−
26 °C) with a 12 h light/dark cycle. Three to four day old male flies
were selected and fed with yeast paste food supplemented with
cocaine to get the final concentration to 15 mM for 3 days. Cocaine-
fed flies were divided into three groups: the first group had continued
cocaine feeding for another 3 days; the second group, the so-called
cocaine removal group, was subsequently fed with normal yeast paste
food without cocaine for 3 days; and the third group was orally
administered with food containing 10 mM MPH for 3 days after
cocaine administration. The feeding dose of 10 mM MPH to flies in
vivo corresponds to a dose of 4.8 mg/kg which is in the range used for
a recent pharmacokinetics and bioavailability study in rats (0.75−10
mg/kg).40,41 After drug treatment, flies from different groups were
placed sequentially on the same fly collars (4 M Instrument & Tool
LLC) and embedded in 10% gelatin.13 The gelatin molds were frozen
at −20 °C and then in liquid nitrogen where the fly-head-embedded
gelatin was detached from the collar. The fly-head-embedded gelatin
was subsequently cut at 12 μm thickness using a cryo-microtome at
−20 °C (Leica CM1520). Sections were thaw-mounted on indium tin
oxide coated glass and freeze-dried overnight in the ToF-SIMS
instrument for further analysis.
ToF-SIMS Analysis: J105. ToF-SIMS analysis was performed
using the J105-3D Chemical Imager (Ionoptika Ltd., UK). The
principle operation of this instrument has been described in detail
elsewhere.42 In our experiments, a GCIB of 40 keV (CO2)6000
+ was
used as a primary ion beam to sputter the sample surface in positive
and negative ion modes. High energy clusters help enhance the
primary and secondary ion yields for intact lipid signals in biological
samples and allow detection of high mass species both on the sample
surface and in the subsurface.19 The spectra were acquired over a
mass range of m/z 100−1000. The image area was 1000 × 1000 μm2
with 128 × 128 pixels for statistical analysis, or with 256 × 256 pixels
for imaging with higher spatial resolution, and the beam size was 6 μm
with a primary ion current of 17 pA, which resulted in the total ion
dose density of 6.1 × 1012 and 1.7 × 1013 ions/cm2, respectively. The
samples were analyzed in the freeze-dried condition at room
temperature.
Data Analysis. SIMCA (Umetrix, Sweden) was used to perform
principal components analysis (PCA) on ToF-SIMS spectra which
were extracted by selecting the region of interest, the central area of
the fly brain, from ToF-SIMS images. All spectra were normalized to
total number of pixels and total ion intensity of the region of interest
to compensate for the variations from ToF-SIMS measurements. PCA
was then applied to this data set after Pareto scaling. Pareto scaling
used square root of standard deviation as a scaling factor to reduce the
dynamic range in the data and emphasize weak peaks that might be
more relevant to biological information.
A t test was performed on the nonscaled peak intensities of the ions
identified in the PCA loadings to compare the data from the cocaine
group with the other groups.
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